Christopher Freeburn

Christopher Freeburn

Christopher T. Freeburn has been a financial writer and editor for more than 10 years. He has worked at industry trade publications like Food Logistics, ChemicalWeek and Institutional Investor. His freelance articles have appeared in a variety of magazines, including Technology Review, Audubon and USA Weekend. He lives in Westchester County, just outside New York City.”

Recent Articles

Monday Apple Rumors: ‘iWatch’ Coming Later This Year

Apple will release a smartwatch this year; Apple paid no U.K. corporation tax last year; and Apple prepares software fix for MacBook Air WiFi problem.

Bond Funds See Record Outflow in June

Investors pulled $80 billion out of mutual and exchange-traded bond funds last month after the Federal Reserve signaled it would slow stimulus spending.

Nokia Shares Soar as It Takes Control of NSN

Finnish handset maker Nokia will purchase the Siemens' 50% stake in their Nokia Siemens Networks joint venture.

Gold Rallies But Ends Quarter with Record Decline

Gold rebounded modestly in Friday trading, but ended the quarter with a record loss.

Friday Apple Rumors: Is Foxconn Trying to Trump the iWatch?

Foxconn will launch its own smartwatch ahead of a rumored Apple iWatch; Apple's new Mac Pro to be pricey; and Apple's new San Francisco store plans criticized.

Details of Facebook’s New Chat Room Feature Leaked

Sources tell TechCrunch that Facebook is testing a chat room feature that would permit a users friends to join in extended discussions.

Gold Continues to Slide While Equities, U.S. Dollar Rally

Vanishing investor confidence in gold's safe haven status sent the precious metal down again in Thursday trading as equities and the U.S. dollar rose.

Thursday Apple Rumors: iPhone Not ‘God of All Smartphones’

Japan's largest wireless carrier isn't sure it needs the iPhone; Apple loses bid to add Samsung Galaxy S4 to lawsuit; Apple to pay $100 million app settlement.

Implantable Drug Pump Recalled After 14 Deaths

The Food and Drug Administration is recalling SynchroMed Implantable Infusion Systems made by Medtronic due to defects that linked to patient deaths.

Mystery Mideast Buyer Wants to Buy Empire State Building

An unnamed group of Middle Eastern investors has made a $2.1 billion bid for New York City's Empire State Building.